In vitro evaluation of the sensitization potential of weak contact allergens using langerhans-like dendritic cells and autologous T cells.

Contact hypersensitivity is a major public health concern in most industrial countries, which is why predictive tests which could identify potential allergens are needed. We have established an in vitro approach for the detection of primary immune response. This model uses Langerhans-like dendritic cells (LLDC) derived from cord blood progenitors and autologous T lymphocytes, isolated from the same blood sample. Treatment of day 12-14 LLDC, with strong haptens trinitrobenzene sulfonic acid (TNP), fluorescein isothiocyanate (FITC) or Bandrowski's base (BB), results in the proliferation of T lymphocytes, whereas weak allergens and irritants, such as sodium dodecyl sulfate (SDS) are ineffective. The use of immature (day 8) LLDC and the addition of a 48 h stage of incubation after hapten contact, result in phenotypic maturation of LLDC in addition to lymphocyte activation in all the cultures with strong haptens. The 48 h stage of incubation, results in sensitization and in some cases the induction of T cell proliferation to citronellal (1/8), coumarine (1/8) and to a prohapten p-phenylenediamine (pPDA; 2/8). The phenotype of DC after 48 h of contact with a strong hapten, becomes that of mature DC (CD83(+), CD86(+) and HLA-DR(++)). With fragrance molecules, weak haptens and prohaptens, a comparable phenotype is observed only when T lymphocytes are activated. These data suggest that the unresponsiveness observed with weak haptens, may be the consequence on an incomplete maturation of LLDC.

[1]  L H Kligman,et al.  In vitro model for contact sensitization: I. Stimulatory capacities of human blood-derived dendritic cells and their phenotypical alterations in the presence of contact sensitizers. , 1997, Toxicology in vitro : an international journal published in association with BIBRA.

[2]  J. Streilein,et al.  In vitro evidence that Langerhans cells can adopt two functionally distinct forms capable of antigen presentation to T lymphocytes. , 1989, Journal of immunology.

[3]  H. Maibach,et al.  The use of graded concentrations in studying skin sensitizers: experimental contact sensitization in man. , 1974, Food and cosmetics toxicology.

[4]  M. Rosenzwajg,et al.  Human dendritic cell differentiation pathway from CD34+ hematopoietic precursor cells. , 1996, Blood.

[5]  O. Majdic,et al.  Cultured human Langerhans cells resemble lymphoid dendritic cells in phenotype and function. , 1989, The Journal of investigative dermatology.

[6]  F. Sallusto,et al.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha , 1994, The Journal of experimental medicine.

[7]  S. Aiba Maturation of dendritic cells induced by cytokines and haptens. , 1998, The Tohoku journal of experimental medicine.

[8]  D. Mauri,et al.  Primary sensitization of human T lymphocytes by cytokine-cultured, peripheral blood monocytes , 1996 .

[9]  D A Basketter,et al.  Comparison of the local lymph node assay with the guinea-pig maximization test for the detection of a range of contact allergens. , 1992, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[10]  D. Schmitt,et al.  Evaluation of the capacity of dendritic cells derived from cord blood CD34+ precursors to present haptens to unsensitized autologous T cells in vitro. , 1998, The Journal of investigative dermatology.

[11]  Marianne Ekman,et al.  Differentiation of human dendritic cells from monocytes in vitro , 1997, European journal of immunology.

[12]  I Kimber,et al.  Dendritic cells and cutaneous immune responses to chemical allergens. , 1992, Toxicology and applied pharmacology.

[13]  J. Saloga,et al.  Flow-cytometric screening for the modulation of receptor-mediated endocytosis in human dendritic cells: implications for the development of an in vitro technique for predictive testing of contact sensitizers. , 1997, Journal of immunological methods.

[14]  S. Katz,et al.  Generation and Characterization of T‐helper Cells by Primary in vitro Sensitization using Langerhans Cells , 1990, Immunological reviews.

[15]  D. Strunk,et al.  Generation of human dendritic cells/Langerhans cells from circulating CD34+ hematopoietic progenitor cells. , 1996, Blood.

[16]  A. Groot,et al.  Patch tests with fragrance materials and preservatives , 1985, Contact dermatitis.

[17]  J. Johansen,et al.  Identification of risk products for fragrance contact allergy: a case-referent study based on patients' histories. , 1998, American journal of contact dermatitis : official journal of the American Contact Dermatitis Society.

[18]  P. Elsner,et al.  Fragrance contact dermatitis: a worldwide multicenter investigation (Part I). , 1996, American journal of contact dermatitis : official journal of the American Contact Dermatitis Society.

[19]  S. Aiba,et al.  Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of co‐stimulatory molecules , 1997, European journal of immunology.

[20]  G. Shearer,et al.  Cell‐mediated cytotoxicity to trinitrophenyl‐modified syngeneic lymphocytes , 1974, European journal of immunology.

[21]  J. Banchereau,et al.  GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells , 1992, Nature.

[22]  C. Picut,et al.  Immunostimulatory capabilities of highly enriched Langerhans cells in vitro. , 1988, The Journal of investigative dermatology.

[23]  M. Udey,et al.  Contact allergens and epidermal proinflammatory cytokines modulate Langerhans cell E-cadherin expression in situ. , 1996, The Journal of investigative dermatology.

[24]  B F Goodwin,et al.  A comparison of three guinea‐pig sensitization procedures for the detection of 19 reported human contact sensitizers , 1981, Contact dermatitis.

[25]  J. Tikerpae,et al.  Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow. , 1992, Journal of immunology.

[26]  R. Steinman,et al.  Proliferating dendritic cell progenitors in human blood , 1994, The Journal of experimental medicine.

[27]  S. Knight,et al.  Dendritic cells and the initiation of contact sensitivity to fluorescein isothiocyanate. , 1986, Immunology.

[28]  A. Enk,et al.  Early molecular events in the induction phase of contact sensitivity. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[29]  D. Schmitt,et al.  In vitro primary sensitization and restimulation of hapten-specific T cells by fresh and cultured human epidermal Langerhans' cells. , 1993, Immunology.

[30]  M. Mohamadzadeh,et al.  Increased level of intracellular MHC class II molecules in murine Langerhans cells following in vivo and in vitro administration of contact allergens. , 1992, The Journal of investigative dermatology.

[31]  J. Tikerpae,et al.  Identification of hematopoietic progenitors of macrophages and dendritic Langerhans cells (DL-CFU) in human bone marrow and peripheral blood. , 1990, Blood.

[32]  R. Steinman,et al.  Antigen processing by epidermal Langerhans cells correlates with the level of biosynthesis of major histocompatibility complex class II molecules and expression of invariant chain , 1990, The Journal of experimental medicine.

[33]  D. Schmitt,et al.  In vitro primary sensitization of hapten‐specific T cells by cultured human epidermal Langerhans cells—a screening predictive assay for contact sensitizers , 1996, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[34]  C. Bucana,et al.  Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. , 1990, Journal of immunology.

[35]  J. Banchereau,et al.  CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha , 1996, The Journal of experimental medicine.